Evercore Comments on Medtronic (MDT)
Tweet Send to a Friend
Evercore Comments on Medtronic (NYSE: MDT)The analyst comments "Today, CMS published in proposed NCD decision memo for Renal Denervation (RDN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


